David Tyronne Howton, Jr
2012
Compensation breakdown
Non-Equity Incentive Plan | $29,006 |
---|---|
Option Awards | $2,760,570 |
Salary | $59,856 |
Other | $459 |
Total | $2,849,891 |
Howton received $2.8M in option awards, accounting for 97% of the total pay in 2012.
Howton also received $29K in non-equity incentive plan, $59.9K in salary and $459 in other compensation.
Rankings
In 2012, David Tyronne Howton, Jr's compensation ranked 2,448th out of 11,487 executives tracked by ExecPay. In other words, Howton earned more than 78.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,448 out of 11,487 | 79th |
Division Manufacturing | 849 out of 4,253 | 80th |
Major group Chemicals And Allied Products | 188 out of 1,198 | 84th |
Industry group Drugs | 109 out of 920 | 88th |
Industry Pharmaceutical Preparations | 88 out of 700 | 87th |
Howton's colleagues
We found seven more compensation records of executives who worked with David Tyronne Howton, Jr at Sarepta Therapeutics in 2012.
2012
Sandesh Mahatme
Sarepta Therapeutics
Chief Financial Officer
2012
David Howton
Sarepta Therapeutics
General Counsel
2012
Christopher Garabedian
Sarepta Therapeutics
Chief Executive Officer
2012
Edward Kaye
Sarepta Therapeutics
Chief Executive Officer
2012
Michael Jacobsen
Sarepta Therapeutics
Vice President, Finance
2012
Jayant Aphale
Sarepta Therapeutics
Senior Vice President, Technical Operations
2012
Effie Toshav
Sarepta Therapeutics